<?xml version="1.0" encoding="UTF-8" ?>
<Journal>
<Journal-Info>
<name>PHARMANEST : An International Journal of Advances in Pharmaceutical Sciences</name>
<website>pharmanest.net</website>
<email>pharmanest@gmail.com</email>
<issn mediatype='print'> 2453-7005 Online: 2343-212X</issn>
<issn mediatype='Online'></issn>
</Journal-Info>
<article>
<title>EFFECT OF TRIPHALA- AN AYURVEDIC HERBAL FORMULATION ON DOXORUBICIN INDUCED CARDIO TOXICITY IN RATS</title>
<authors>MITRA M, SHIVALINGEGOWDA KP*</authors>
<keywords>Triphala, cardiotoxicity, catalase, lactate dehydragenase, electrocardiogram</keywords>
<pages>1131-1141</pages>
<issue_number>Volume 4, Issue 6</issue_number>
<issue_period>November - December 2013</issue_period>
<abstract>The objective was to evaluate the cardioprotective activity of triphala in doxorubicin induced cardiotoxicity in albino wistar rats. Twenty- four rats were divided into four groups (n=6). Group I (normal) received normal saline (p.o.) for 10 days. The group II rats received doxorubicin HCl (15mg/kg, i.p.) on 7th day. The rats in group III and IV were pretreated with triphala (500mg/kg, p.o. and 1000 mg/kg, p.o.) followed by doxorubicin on 7thday. On 11th day, ECG studies, serum creatinine phosphokinase (CPK), CK-MB and lactate dehydrogenase (LDH) levels as well as anti-oxidant parameters like superoxide dismutase, catalase and lipid peroxidation along with histopathological changes were studied. The doxorubicin treated rats have shown abnormal ECG values along with elevated (*** P </abstract>
</article>
</Journal>
